Native Alignment in the Setting of an Arthritic Knee in Total Knee Arthroplasty

March 20, 2026 updated by: Arthur Malkani, University of Louisville

The goal of this clinical trial is to learn if preparing the target alignment of the operative side in total knee arthroplasty (TKA) based on the non-arthritic side will give the patient better overall alignment, function, and improved results compared to basing our implant alignment and positioning off the arthritic side, which is currently the traditional method.

The main questions it aims to answer are:

  • Will a patient have improved postoperative TKA results if the implant alignment is based off the non-arthritic side compared to the standard arthritic side?
  • What are the similarities or differences between study arms with respect to final implant alignment and positioning angles? Researchers will compare the outcomes of two cohorts of patients undergoing primary robotic-assisted total knee arthroplasty (RA-TKA) with normal contralateral knee. Based on preoperative CT imaging, the researchers will use normal contralateral side joint numbers as the target alignment for one group (Experimental arm) and utilize the traditional method for the other group (Active comparator arm). Clinical outcomes and patient-reported outcome measures (PROMs) will be compared between groups.

Participants will:

  • Be randomized into one of two study arms and will receive either a unilateral knee CT or bilateral knee CT preoperatively
  • Follow-up in the clinic at 2 weeks, 6 weeks and 1-year postoperatively, per standard-of-care for x-ray and clinical evaluation.
  • Complete postop questionnaires (PROMs) at the prescribed follow-up intervals

Study Overview

Study Type

Interventional

Enrollment (Actual)

1

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kentucky
      • Louisville, Kentucky, United States, 40202
        • UofL Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patient age is 21-89 at time of surgery
  2. Patient is indicated to undergo a unilateral primary TKA, secondary to osteoarthritis
  3. Patient's contralateral knee is non-arthritic
  4. Patient agrees to participate as a study subject and signs the Informed Consent and Research Authorization document
  5. Patient is able to read and speak English.

Exclusion Criteria:

  1. Patient is under the age of 21
  2. Patient's primary diagnosis is not osteoarthritis
  3. Patient is unable to read and speak English
  4. History of previous DVT/PE
  5. History of stroke, CABG, or A fib
  6. Current smoker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Participant receives bilateral knee CT preoperatively
The P.I. (Dr. Malkani) will use normal contralateral side joint numbers as the target alignment for RA-TKA
Intervention given to the Experimental Arm
Active Comparator: Participant receives unilateral CT of the operative knee preoperatively
The P.I. will use the traditional method to obtain target alignment for RA-TKA.
Intervention given to the Active Comparator arm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall Satisfaction
Time Frame: 1-year postoperatively
Overall Satisfaction with TKA using a Likert scale
1-year postoperatively
Pain VAS
Time Frame: preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
Level of knee pain (scale of zero to ten) using the Visual Analog Scale (VAS)
preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
KOOS JR
Time Frame: preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
KOOS JR questionnaire
preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
Forgotten Joint Score
Time Frame: preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
FJS-12 questionnaire
preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
PROMIS-10 Mental and Physical Health scores
Time Frame: preoperatively and 1-year postoperatively
PROMIS-10 Global Health questionnaire
preoperatively and 1-year postoperatively
Incidence of revision TKA
Time Frame: 1 year postop
postoperative complication requiring a revision total knee arthroplasty
1 year postop
non-revision complication
Time Frame: 1 year postop
postoperative complication requiring a non-revision procedure
1 year postop

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Active ROM
Time Frame: preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
Active knee range of motion: active extension, active flexion
preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2024

Primary Completion (Actual)

February 27, 2026

Study Completion (Actual)

March 2, 2026

Study Registration Dates

First Submitted

September 25, 2024

First Submitted That Met QC Criteria

September 25, 2024

First Posted (Actual)

September 27, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2026

Last Update Submitted That Met QC Criteria

March 20, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis (OA) of the Knee

Clinical Trials on CT scan bilateral knee

Subscribe